A SEVERE CASE WITH RELAPSING BULLOUS TOXICODERMA

O. Yu Olisova , A. A Khaldin , N. P Teplyuk , O. V Grabovskaya , D. V Ignatyev , E. Yu Vertieva

Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (5) : 22 -25.

PDF
Russian Journal of Skin and Venereal Diseases ›› 2012, Vol. 15 ›› Issue (5) : 22 -25. DOI: 10.17816/dv36736
Articles
research-article

A SEVERE CASE WITH RELAPSING BULLOUS TOXICODERMA

Author information +
History +
PDF

Abstract

Toxic epidermal necrolysis in a female patient aged 68 years was caused by therapy with SH group containing drugs. The patient was treated by metiprede in the maximum daily dose of 48 mg, which was gradually reduced as a significant improvement was attained.

Keywords

toxic epidermal necrolysis (TEN) / TEN-inducing drug classification / pathogenesis / TEN severity index / total systems glucocorticoids

Cite this article

Download citation ▾
O. Yu Olisova, A. A Khaldin, N. P Teplyuk, O. V Grabovskaya, D. V Ignatyev, E. Yu Vertieva. A SEVERE CASE WITH RELAPSING BULLOUS TOXICODERMA. Russian Journal of Skin and Venereal Diseases, 2012, 15(5): 22-25 DOI:10.17816/dv36736

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Chung W.H., Hung S.I., Yang J.Y., Su S.C., Huang S.P., Wei C.Y., et al. Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis. Nat. Med. 2008; 14(12): 1343—50.

[2]

Sun-Hee Choi, Yu-Min Lee, Yeong-Ho Rha Korean J. Pediatr. 2009; 52(2): 247—50.

[3]

Grosber M., Carsin H., Leclerc F. Epidermal necrolysis in association with Mycoplasma pneumonia infection. J. Invest. Dermatol. 2006, 126(1): 23.

[4]

Guégan S., Bastuji-Garin S., Poszepczynka-Guigne E., Roujeau J.C., Revuz J. Performance of the SCORTEN during the first five days of hospitalization to predict the prognosis of epidermal necrolysis. J. Invest. Dermatol. 2006; 126(2): 272—6.

[5]

Lonjou C., Thomas L., Borot N., Ledger N., de Toma C., LeLouet H., et al.; RegiSCAR Group. A marker for Stevens-Johnson syndrome..: ethnicity matters. Pharmacogenomics J. 2006; 6(4): 265—8.

[6]

Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br. J. Dermatol. 1956; 68(11): 355—61.

[7]

Magina S., Lisboa C., Leal V., Palmares J., Mesquita-Guimames J. Dermatological and ophthalmological sequels in toxic epidermal necrolysis. Dermatology 2003; 207(1): 33—6.

[8]

Mockenhaupt M. Severe cutaneous adverse reactions. Braun-Falco’s Dermatology Heidelberg: Springer Medizin Verlag; 2008: 473—83.

[9]

Mockenhaupt M. The current understanding of Stevens-Johnson syndrome and toxic epidermal necrolysis Expert. Rev. Clin. Immunol. 2011; 7(6): 803—15.

[10]

Revuz J., Penso D., Roujeau J.C., Guillaume J.C., Payne C.R., Wechsler J., Touraine R. Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients. Arch. Dermatol. 1987; 123(9): 1160—5.

RIGHTS & PERMISSIONS

Eco-Vector

AI Summary AI Mindmap
PDF

171

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/